Last reviewed dd mmm yyyy. Last edited dd mmm yyyy
Mavacamten for treating symptomatic obstructive hypertrophic cardiomyopathy
Mavacamten is recommended as an option for treating symptomatic obstructive hypertrophic cardiomyopathy in adults who have a New York Heart Association class of 2 or 3.It is recommended only if:
The NICE committee note:
A review states:
Reference:
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.